SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Regulus Therapeutics Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - April 30, 2025) - Rigrodsky Law, P.A. is investigating Regulus Therapeutics Inc. ("Regulus") (NASDAQ: RGLS) regarding possible breaches of fiduciary duties and other violations of law related to Regulus' agreement to be acquired by Novartis AG. Under the terms of the agreement, Regulus shareholders will receive $7.00 per share in cash.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-regulus-therapeutics-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call (302) 295-5310 or email [email protected].

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250335

You May Also Be Interested In

• Buffalo Potash to Present at the ArcStone Kingswood Growth Summit 2026
• Getting Lucky: Meet 7 New Penguin Chicks at Ripley's Aquarium of Myrtle Beach
• RMTG's Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint